SEC Form 4 · accession 0001257171-17-000030
Ainos, Inc. · AIMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen T Chen
Officer — President, CEO & Chairman · Director · 10% Owner
Period of report
Jul 5, 2017
Accepted (ET)
Jul 7, 2017 · 3:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001014763
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 5, 2017 | A | 76,095 | $0.2464 | A | 3,045,206 | D | |
| Common StockF1 | Jul 5, 2017 | P | 1,250 | $0.278 | A | 110,727 | I | Spouse |
| Common StockF1 | Jul 5, 2017 | P | 750 | $0.29 | A | 111,477 | I | Spouse |
| Common StockF2 | holding | — | — | — | 39,473 | I | ACTS Biosciences, Inc. | |
| Common StockF3 | holding | — | — | — | 638,801 | I | STC International, Inc. |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1SPOUSE - VIRGINIA M CHEN IRA
- F2STEPHEN CHEN IS CHAIRMAN AND A BOARD MEMBER OF ACTS BIOSCIENCES, INC.
- F3STEPHEN CHEN IS CHAIRMAN, BOARD MEMBER AND MAJOR SHAREHOLDER OF STC INTERNATIONAL, INC.